Unlock instant, AI-driven research and patent intelligence for your innovation.

A polypeptide targeting human cancer cells and its application

A cancer cell and targeting technology, applied in the preparation of anticancer drugs or imaging preparations, polypeptides and their application fields, can solve the problems of high cost, cumbersome preparation, weak penetrating power, etc., and achieve small molecular weight and high purity High, selective effect

Active Publication Date: 2016-10-05
THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although antibodies are widely used in clinical diagnosis due to their specific targeting, they have disadvantages such as cumbersome preparation, poor stability, high cost, and weak penetration.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A polypeptide targeting human cancer cells and its application
  • A polypeptide targeting human cancer cells and its application
  • A polypeptide targeting human cancer cells and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Construction of polypeptide library and screening of APN targeting polypeptide

[0042] 1. Experimental instruments and materials

[0043] N-methylmorpholine (NMM), piperidine, trifluoroacetic acid (TFA), dichloromethane (DCM), ninhydrin, vitamin C, phenol, tetramethyluronium hexafluorophosphate (HBTU), hexahydro Pyridine, triisopropylsilane (TIS), ethanedithiol (EDT), N,N dimethylformamide (DMF), anhydrous ether, resin, methanol, various Fmoc protected amino acids, peptide synthesis tubes, shaking Bed, vacuum water pump, rotary evaporator, above reagents and materials were obtained from commercial sources.

[0044] 2. Synthesis of "one bead, one object" polypeptide library

[0045] The peptide library was synthesized by Fmoc solid-phase peptide synthesis method, and the chemical formula constructed by screening the peptide library of APN target peptide was as follows: figure 1 shown. The specific method is to randomly couple amino acids one by one to the ...

experiment example 1

[0051] Experimental Example 1 Detection of affinity between polypeptide and human aminopeptidase N (APN) protein by surface plasmon resonance imaging (SPRi) method

[0052] Spot 1mg / mL AP-1, AP-2, AP-3, AP-4 and 1×PBS (phosphate buffer) onto the chip, incubate overnight at 4°C under humid conditions, then wash with 10×PBS for 10min , then wash with 1×PBS for 10min, and finally wash twice with deionized water, 10min each time, immerse in 1×PBS containing 5% milk, incubate overnight at 4°C, then wash with 10×PBS for 10min, 1× Wash with PBS for 10 min, and finally wash twice with deionized water for 10 min each time, blow dry with nitrogen, and install the chip on the machine (Plexera HT surface plasmon resonance imaging system).

[0053] The mobile phase was sequentially passed through 1×PBS, 2×PBS, 1.25 μg / mL, 2.5 μg / mL, 5 μg / mL, 10 μg / mL and 20 μg / mL of APN purified protein, and the SPRi signal was recorded and analyzed.

[0054] binding effect as figure 2 As shown, the b...

experiment example 2AP-1

[0055] Experimental Example 2 Interaction of AP-1, AP-2, AP-3, AP-4 with APN-positive cells SKOV-3 and APN-negative cells 293A

[0056] AP-1, AP-2, AP-3, fluorescein isothiocyanate (FITC) conjugates of AP-4 are obtained by solid-phase synthesis, AP-1 obtained in Example 1, AP-2, Continue to couple ε-aminocaproic acid to the AP-3 and AP-4 polypeptide microbeads. In a solution of pyridine / N,N dimethylformamide / dichloromethane at a ratio of 1:5:7, FITC was mixed with peptide beads and reacted overnight.

[0057] The FITC conjugates of AP-1, AP-2, AP-3 and AP-4 were obtained after trifluoroacetic acid cleavage. Polypeptide SP was coupled with FITC according to the above method, and the SP-FITC conjugate was obtained as a control. MALDI-TOF identification and HPLC purification were used for subsequent experiments.

[0058] The human ovarian cancer cell line SKOV-3 was cultured in McCoy’s 5A medium containing 100 mL / L fetal bovine serum at 1×10 5 / mL cell concentration into a ro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a polypeptide targeting human cancer cells and its application. The polypeptide is shown in the following general formula: YX 1 x 2 x 3 x 4 x 5 C; the amino acid residues of the polypeptide are L-type and / or D-type; the present invention also relates to a conjugate obtained by coupling the polypeptide with a carrier and the polypeptide, the bivalent body or multivalent body formed by it Application in the preparation of medicines or imaging preparations for treating, preventing or diagnosing cancer. The polypeptide of the present invention can specifically bind to the cancer cell marker human aminopeptidase N (Aminopeptidase N, APN), which makes up for the shortcomings of cumbersome preparation, poor stability, high cost, and weak penetration of biological preparations such as antibodies, and can be used to prepare Diagnostic reagents and targeting probes for cancer.

Description

technical field [0001] The present invention relates to the field of medicinal chemistry, in particular to a polypeptide and its application, in particular to a polypeptide targeting human cancer cells, a product derived from the peptide and capable of binding to human aminopeptidase protein, the above polypeptide or its The application of the derived product in the preparation of anticancer drugs or imaging preparations. Background technique [0002] Cancer is a leading cause of death worldwide. Data show that in 2012 there were approximately 14.1 million new cancer cases and 8.2 million cancer deaths worldwide, compared with 12.7 million and 7.6 million in 2008. The most common cancers diagnosed worldwide were lung cancer (1.8 million, 13%), breast cancer (1.7 million, 11.9%), and colorectal cancer (1.4 million, 9.7%), and the leading cause of death was lung cancer (1.6 million, 19.4%), liver cancer (800,000, 9.1%) and gastric cancer (700,000, 8.8%). [0003] The invasio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06A61K47/48A61K47/42A61K49/00
Inventor 王蔚芝王子华胡志远
Owner THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA